Daniel Mark Blumenthal, M.D.
This page shows the publications co-authored by Daniel Blumenthal and Jason Wasfy.
Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007237.
Anatomical versus Functional Testing for Coronary Artery Disease. N Engl J Med. 2015 07 02; 373(1):90.
Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease. JAMA Netw Open. 2021 Jun 01; 4(6):e2112800.
Differences in Medicare Beneficiary Risk Scores by Physician's International Medical Graduate Status. J Gen Intern Med. 2019 07; 34(7):1110-1112.
Patient-Reported Outcomes in Cardiology. Circ Cardiovasc Qual Outcomes. 2018 11; 11(11):e004794.
A Survey of Interventional Cardiologists' Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention. JAMA Cardiol. 2018 07 01; 3(7):629-634.
Utilization of stress testing for low-risk patients with chest discomfort in the emergency department. J Nucl Cardiol. 2019 10; 26(5):1642-1646.
Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record. Circ Cardiovasc Qual Outcomes. 2015 Sep; 8(5):477-85.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.